Accelerated Hyperfractionated Radiotherapy and Concurrent Protracted Venous Infusion Chemotherapy in Locally Advanced Head and Neck Cancer
Significance of Margins of Excision on Breast Cancer Recurrence
Anaplastic Thyroid Carcinoma
Phase I/II Trial of Accutane as a Potentiator of Carboplatin and Paclitaxel in Squamous Cell Carcinomas
Phase II Study of Dolastatin-10 as First-Line Treatment for Advanced Colorectal Cancer
Expression of the Murine Double Minute Gene 2 Oncoprotein in Esophageal Squamous Cell Carcinoma as a Novel Marker for Lack of Response to Chemoradiotreatment
Chemoimmunohormonal Therapy With Carmustine, Dacarbazine, Cisplatin, Tamoxifen, and Interferon for Metastatic Melanoma
Serial Public Cancer Screening in China
Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma
Tumor Lysis Syndrome in Extensive-Stage Small-Cell Lung Cancer
Results of Recent Therapy for Non–Small-Cell Lung Cancer With Brain Metastasis as the Initial Relapse
Second-Line Chemotherapy With Irinotecan and Vinorelbine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Organ Preservation With Interstitial Radiation for Base of Tongue Cancer
Dose-Intense Ifosfamide/Doxorubicin/Cisplatin Based Chemotherapy for Osteosarcoma in Adults
Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix
Aggressive Non-Hodgkin’s Lymphoma Treated at the Institute of Oncology, Istanbul
Phase II Study of Docetaxel and Gemcitabine Combination Chemotherapy in Non–Small-Cell Lung Cancer Patients Failing Previous Chemotherapy
Hemorrhagic Cystitis as an Unexpected Adverse Reaction to Temozolomide
Carboplatin and Vinblastine for the Treatment of Metastatic Transitional Cell Carcinoma of the Urothelial Tract
CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer
Phase I Trial of Gemcitabine, Administered as a Standard and Constant Dose-Rate Infusion, in Combination With Paclitaxel in Patients With Advanced Solid Tumors (LOA-2)
Phase I Clinical Trial of Irinotecan With Oral Capecitabine in Patients With Gastrointestinal and Other Solid Malignancies
The Corporate Presence at Oncology Meetings
Palliative Treatment: What’s the Point?